These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8101876)

  • 1. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.
    Romero AG; Leiby JA; McCall RB; Piercey MF; Smith MW; Han F
    J Med Chem; 1993 Jul; 36(15):2066-74. PubMed ID: 8101876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
    Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
    J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
    Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
    J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
    Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
    J Med Chem; 1994 Sep; 37(20):3263-73. PubMed ID: 7932553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.
    McCall RB; Romero AG; Bienkowski MJ; Harris DW; McGuire JC; Piercey MF; Shuck ME; Smith MW; Svensson KA; Schreur PJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):875-83. PubMed ID: 7965808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.
    Bromidge SM; Dabbs S; Davies DT; Davies S; Duckworth DM; Forbes IT; Gaster LM; Ham P; Jones GE; King FD; Mulholland KR; Saunders DV; Wyman PA; Blaney FE; Clarke SE; Blackburn TP; Holland V; Kennett GA; Lightowler S; Middlemiss DN; Trail B; Riley GJ; Wood MD
    J Med Chem; 2000 Mar; 43(6):1123-34. PubMed ID: 10737744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-9 and N-substituted analogs of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3- propyl-1H-benz[e]indole-9-carboxamide: 5-HT1A receptor agonists with various degrees of metabolic stability.
    Haadsma-Svensson SR; Svensson K; Duncan N; Smith MW; Lin CH
    J Med Chem; 1995 Feb; 38(4):725-34. PubMed ID: 7861420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.
    Ennis MD; Hoffman RL; Ghazal NB; Olson RM; Knauer CS; Chio CL; Hyslop DK; Campbell JE; Fitzgerald LW; Nichols NF; Svensson KA; McCall RB; Haber CL; Kagey ML; Dinh DM
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2369-72. PubMed ID: 12824036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties.
    Laban U; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE
    Bioorg Med Chem Lett; 2001 Mar; 11(6):793-5. PubMed ID: 11277522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
    Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
    J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
    Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
    J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
    Isaac M; Slassi M; Xin T; Arora J; O'Brien A; Edwards L; MacLean N; Wilson J; Demschyshyn L; Labrie P; Naismith A; Maddaford S; Papac D; Harrison S; Wang H; Draper S; Tehim A
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4409-13. PubMed ID: 14643336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.
    Stjernlöf P; Ennis MD; Hansson LO; Hoffman RL; Ghazal NB; Sundell S; Smith MW; Svensson K; Carlsson A; Wikström H
    J Med Chem; 1995 Jun; 38(12):2202-16. PubMed ID: 7783152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
    Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
    J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
    J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
    Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall PA; Svensson K; Ekman A; Carlsson A
    J Med Chem; 1992 Oct; 35(22):3984-90. PubMed ID: 1433207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT
    Pessoa-Mahana H; Silva-Matus P; Pessoa-Mahana CD; Chung H; Iturriaga-Vásquez P; Quiroz G; Möller-Acuña P; Zapata-Torres G; Saitz-Barría C; Araya-Maturana R; Reyes-Parada M
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27981607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.